Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ifigènia Saborit-Villarroya
The Hsp90 Inhibitor IPI-504 Overcomes Bortezomib Resistance in Mantle Cell Lymphoma in Vitro and in Vivo by Down-Regulation of the Prosurvival ER Chaperone BiP/Grp78
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The Adaptor Protein 3BP2 Binds Human CD244 and Links This Receptor to Vav Signaling, ERK Activation, and NK Cell Killing
Journal of Immunology
Allergy
Immunology
Related publications
Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CDK5 Inhibition In�vitro and in Vivo Induces Cell Death In�myeloma and Overcomes the Obstacle of Bortezomib Resistance
International Journal of Molecular Medicine
Medicine
Genetics
In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma
Haematologica
Hematology
The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment
Frontiers in Pharmacology
Pharmacology
Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-Cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Effects of the Proteasome Inhibitor Bortezomib in Combination With Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-Analysis
Turkish Journal of Haematology
Hematology
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
